Ciprofloxacin for Soft Tissue Infections
Specific Clinical Scenarios Where Ciprofloxacin Excels
- Pseudomonas skin infections following exposure to inadequately chlorinated swimming pools or hot tubs—ciprofloxacin offers an oral treatment option that may be preferred over parenteral therapy 1
- Complicated soft tissue infections in injection drug users where broad-spectrum coverage against aerobic and anaerobic organisms is needed, though ciprofloxacin must be combined with metronidazole for anaerobic coverage 2
Critical Limitations
- No activity against MRSA—use vancomycin, linezolid, daptomycin, or oral alternatives (trimethoprim-sulfamethoxazole, doxycycline, clindamycin) instead 3
- Inadequate for necrotizing infections—these require combination therapy with clindamycin plus piperacillin-tazobactam or ceftriaxone plus metronidazole 3
- Not appropriate for animal or human bites—amoxicillin-clavulanate is required for anaerobic coverage 3
- Insufficient for diabetic foot infections of moderate-to-severe severity—broader spectrum coverage is necessary 3
First-Line Agents Are Superior for Common Infections
- Cephalexin is the preferred first-line agent for mild, uncomplicated skin and soft tissue infections caused by susceptible Staphylococcus aureus and Streptococcus pyogenes 3
Combination Therapy Requirements
- For dirty post-operative wounds involving intestinal or genitourinary tract, combination regimens such as ciprofloxacin plus metronidazole are recommended by the American College of Surgeons 4